Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,3412,360 of 20,252 grants

Active NON-SBIR/STTR RPGS
Lipid storage and catabolism as drivers of metastatic invasion
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2028

Metastasis is the primary cause of cancer death, yet therapeutic strategies to inhibit metastatic invasion do not exist. The long-term goal of our research program is to define the...

$3.69M
USD
Active NON-SBIR/STTR RPGS
Liquid biopsy and radiomics for liver cancer surveillance
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

ABSTRACT Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer death in the United States. While prevention efforts are paramount, most patients succumb to advanced...

$7.2M
USD
Active NON-SBIR/STTR RPGS
Radiobioeffect Modeling of αRPT
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

If absorbed dose is to be used in treatment-planning based α-particle emitter radiopharmaceutical therapy (αRPT), the impact of DNA double-strand break (DSB) repair status- the pro...

Active OTHER RESEARCH-RELATED
Educational Pathways for Cancer Research (EPCR)
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2028

The aim of Educational Pathways for Cancer Research (EPCR) at the Indiana University Simon Comprehensive Cancer Center (IUSCCC) and the Indiana University Bloomington (IUB) School...

$3.72M
USD
Active NON-SBIR/STTR RPGS
A platform to identify in vivo targets of covalent cancer drugs in 3D tissues
NATIONAL CANCER INSTITUTE Scripps Research Institute, The United States 2023 – 2026

Abstract Covalent inhibitors represent some of the most successful drugs in human history, including aspirin and penicillin. Recently, targeted covalent drugs have taken center sta...

$4.51M
USD
Active NON-SBIR/STTR RPGS
Immunotherapeutic targeting of gangliosides in Ewing Sarcoma
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

Project Summary Ewing sarcoma (EWS) is the second most common tumor involving bone in children and young adults and is fatal in most patients with metastatic or relapsed disease. P...

$7.95M
USD
Completed OTHER RESEARCH-RELATED
Enhancing Diversity and Addressing Disparities at the 7th Cancer Cachexia Conference
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2023 – 2024

ABSTRACT This proposal requests partial support for the 7th Cancer Cachexia Conference organized by the Cancer Cachexia Society (CCS), to be held from September 28-30, 2023, in Edi...

$150K
USD
Completed NON-SBIR/STTR RPGS
Antitumor potential of AvFc lectibody in non-small cell lung cancer
NATIONAL CANCER INSTITUTE University of Louisville United States 2023 – 2025

PROJECT SUMMARY / ABSTRACT The goal of this project is to develop a novel tumor glycobiomarker-targeting agent against non-small cell lung cancer (NSCLC). NSCLC accounts for the ma...

$4.02M
USD
Active NON-SBIR/STTR RPGS
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2023 – 2027

Glioblastoma (GBM) is the most lethal form of brain cancer. Treatment options are limited, in part because of inefficient drug delivery across the blood-brain barrier (BBB). GBM mi...

$5.77M
USD
Active NON-SBIR/STTR RPGS
Investigating mechanisms of bladder cancer metastasis
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

The major cause of bladder cancer deaths is due to metastasis, yet to date metastatic bladder cancer (mMIBC) has not been extensively studied and many salient issues remain unresol...

$5.17M
USD
Active RESEARCH CENTERS
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

The overall goal of the MD Anderson Cancer Center SPORE in Ovarian Cancer is to test and translate novel therapeutic strategies, including those to overcome adaptive resistance to...

$21.97M
USD
Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Core A: Administrative Core SUMMARY/ ABSTRACT The overall goal of the MD Anderson Cancer Center SPORE in Ovarian Cancer is to translate high-quality research into improved clinical...

Active NON-SBIR/STTR RPGS
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Over 1.7 million core needle breast biopsies are performed in the U.S. every year among women with either a palpable mass or a suspicious finding on breast...

$8.4M
USD
Active RESEARCH CENTERS
The SIK2 Inhibitor GRN-300 Enhances PARP Inhibitor Sensitivity and Cytotoxic T-Cell Function in Ovarian Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Ovarian cancer is a significant cause of morbidity and mortality that affects nearly 300,000 women worldwide each year. Its poor outcomes relate to delayed diagnosis and developmen...

Active NON-SBIR/STTR RPGS
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

PROJECT SUMMARY Tumor growth and response to therapy, particularly immunotherapy, are all highly dependent on the tumor microenvironment (TME): the collection of cells and extracel...

$10.32M
USD
Active NON-SBIR/STTR RPGS
Multifactor risk scores with susceptibility gene mutations to enhance risk assessment of pancreatic cancer
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT We propose to improve risk assessment of pancreatic ductal adenocarcinoma (PDAC), a major lethal cancer for which no early detection strategy exists. We...

$1.42M
USD
Active NON-SBIR/STTR RPGS
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
NATIONAL CANCER INSTITUTE University of Utah United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Tobacco is the leading cause of preventable death and disease and is linked to approximately 20 cancers. The rate of decline of tobacco use has been lower...

$2.49M
USD
Active NON-SBIR/STTR RPGS
Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2028

PROJECT SUMMARY Although multiple myeloma (MM) is the most common blood cancer in Black/African American (AA) individuals, AA patients have been significantly underrepresented in M...

$4.67M
USD
Active NON-SBIR/STTR RPGS
Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Tumor suppressor gene speckle-type POZ protein (SPOP), a substrate adaptor of cullin3-RING ubiquitin ligase, demonstrates heterozygous missense mutations i...

$6.35M
USD
Active RESEARCH CENTERS
Center for Cancer Systems Therapeutics (CaST)
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

PROJECT SUMMARY Patients with aggressive cancers often present with no pharmacologically actionable mutations and poor or no sensitivity to immune checkpoint blockade, thus derivin...

$17.54M
USD